Novartis AG NVS reported first-quarter 2025 adjusted earnings per share of $2.28, beating the street view of $2.10 . Quarterly sales of $13.23 billion ...
SciQuus Oncology Competitors or Alternatives
SciQuus Oncology's top competitors include Palette Life, NovaBay and TAE Life Sciences.
SciQuus Oncology VS Palette Life
Palette Life is SciQuus Oncology's biggest rival. Palette Life was founded in Solna, Stockholms län} in 2018. Like SciQuus Oncology, Palette Life also competes in the Biotechnology sector. Compared to SciQuus Oncology, Palette Life generates $15M more revenue.
SciQuus Oncology VS NovaBay
NovaBay is SciQuus Oncology's #2 rival. NovaBay's headquarters is in Emeryville, California, and was founded in 2000. Like SciQuus Oncology, NovaBay also competes in the Biotechnology space. NovaBay generates ∞% of SciQuus Oncology's revenue.
SciQuus Oncology VS TAE Life Sciences
TAE Life Sciences is SciQuus Oncology's #3 competitor. TAE Life Sciences was founded in 2017 in Irvine, California. Like SciQuus Oncology, TAE Life Sciences also works within the Biotechnology sector. TAE Life Sciences generates $6M more revenue than SciQuus Oncology.
Looking for similar companies to SciQuus Oncology?
Similar Companies
Life Sciences companies in San Diego County
See 29 companies
Biotechnology companies in La JollaSee 44 companies
Life Sciences companies in CaliforniaSee 94 companies
Pharmaceuticals & Biotechnology companies in La JollaSee 55 companies
Life Sciences companies in USASee 398 companies
Life Sciences companies in North AmericaSee 430 companies
Biotechnology companies in San Diego CountySee 686 companies
Pharmaceuticals & Biotechnology companies in San Diego CountySee 904 companies
Biotechnology companies in CaliforniaSee 3,096 companies
Trending News for SciQuus Oncology and SciQuus Oncology's Competitors
Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology, today announced that data from the investigator sponsored NEOASIS study were presented in an o...
One abstract accepted as platform presentation in prestigious Presidential Symposium, demonstrating potent combination of epigenetic regulation and cap...
Bristol Myers Squibb (NYSE:BMY) recently reported its first-quarter results, with adjusted earnings of $1.80 per share on revenue of $11.2 billion. Thi...
Pfizer Inc. reported earnings results for the first quarter ended March 30, 2025. For the first quarter, the company reported revenue was USD 13,715 mi...
NEW BRUNSWICK (dpa-AFX) - Johnson & Johnson (JNJ) announced the FDA has approved IMAAVY, a human FcRn-blocking monoclonal antibody, for the treatment o...
In This Article: THOUSAND OAKS, Calif. , April 28, 2025 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that it will report its first quarter 2025 ...
Novartis plans to acquire Regulus Therapeutics for $7.00 per share in cash, or $800 million, the microRNA specialist said Wednesday. This is more than ...
LEXINGTON, Mass.--(BUSINESS WIRE)-- Agenus Inc. (Agenus) (Nasdaq: AGEN), a leader in developing novel immunological agents to treat various cancers, to...
The trial met its primary endpoint of event-free survival (EFS) by investigator assessment, demonstrating a clinically meaningful and statistically sig...
Frequently Asked Questions about SciQuus Oncology
Who are SciQuus Oncology's top competitors?
SciQuus Oncology's top 3 competitors are Palette Life, NovaBay, TAE Life Sciences.Who is similar to SciQuus Oncology?
Palette Life is the most similar to SciQuus Oncology. NovaBay and TAE Life Sciences are also similar to SciQuus Oncology.
Are SciQuus Oncology and Palette Life competitors?
Yes, Palette Life is one of SciQuus Oncology’s top competitors.